Cargando…

A Multi-Omics Network of a Seven-Gene Prognostic Signature for Non-Small Cell Lung Cancer

There is an unmet clinical need to identify patients with early-stage non-small cell lung cancer (NSCLC) who are likely to develop recurrence and to predict their therapeutic responses. Our previous study developed a qRT-PCR-based seven-gene microfluidic assay to predict the recurrence risk and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Qing, Falatovich, Brianne, Singh, Salvi, Ivanov, Alexey V., Eubank, Timothy D., Guo, Nancy Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745553/ https://www.ncbi.nlm.nih.gov/pubmed/35008645 http://dx.doi.org/10.3390/ijms23010219

Ejemplares similares

Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival
por: Ye, Qing, et al.
Publicado: (2022)

Immune-Omics Networks of CD27, PD1, and PDL1 in Non-Small Cell Lung Cancer
por: Ye, Qing, et al.
Publicado: (2021)

Molecular Analysis of ZNF71 KRAB in Non-Small-Cell Lung Cancer
por: Ye, Qing, et al.
Publicado: (2021)

Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer
por: Sun, YuanLin, et al.
Publicado: (2022)

Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma
por: Park, Junseong, et al.
Publicado: (2019)

The Need for Multi-Omics Biomarker Signatures in Precision Medicine
por: Olivier, Michael, et al.
Publicado: (2019)

Multi-omic network signatures of disease
por: Gibbs, David L., et al.
Publicado: (2014)

Inferencing Bulk Tumor and Single-Cell Multi-Omics Regulatory Networks for Discovery of Biomarkers and Therapeutic Targets
por: Ye, Qing, et al.
Publicado: (2022)

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021)

Multi-Omic Signatures of Sarcoidosis and Progression in Bronchoalveolar Lavage Cells
por: Konigsberg, Iain R., et al.
Publicado: (2023)

Multi-omics analysis of an immune-based prognostic predictor in non-small cell lung cancer
por: Zheng, Yang, et al.
Publicado: (2021)

Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures
por: Xiong, Yi, et al.
Publicado: (2020)

Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma
por: Ding,, Dongxiao, et al.
Publicado: (2023)

Integrative analysis of multi‐omics data reveals the heterogeneity and signatures of immune therapy for small cell lung cancer
por: Chen, Yabin, et al.
Publicado: (2021)

Multi-omics signatures of the human early life exposome
por: Maitre, Léa, et al.
Publicado: (2022)

An individualized prognostic signature and multi-omics distinction for early stage hepatocellular carcinoma patients with surgical resection
por: Ao, Lu, et al.
Publicado: (2016)

Multi-Omics Approaches Identify Necroptosis‑Related Prognostic Signature and Associated Regulatory Axis in Cervical Cancer
por: Zhan, JuanMei, et al.
Publicado: (2022)

An Integrated Immune-Related Bioinformatics Analysis in Glioma: Prognostic Signature’s Identification and Multi-Omics Mechanisms’ Exploration
por: Fan, Xin, et al.
Publicado: (2022)

Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verification Study
por: Zhang, Jin, et al.
Publicado: (2023)

A novel prognostic signature of seven genes for the prediction in patients with thymoma
por: Li, Qiang, et al.
Publicado: (2018)

A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2020)

Biomarker signature identification in “omics” data with multi-class outcome
por: Lagani, Vincenzo, et al.
Publicado: (2013)

MOUSSE: Multi-Omics Using Subject-Specific SignaturEs
por: Fiorentino, Giuseppe, et al.
Publicado: (2021)

Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy
por: Tong, M, et al.
Publicado: (2016)

Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence
por: Xu, Zhipeng, et al.
Publicado: (2021)

Predicting recurrence and metastasis risk of endometrial carcinoma via prognostic signatures identified from multi-omics data
por: Li, Ling, et al.
Publicado: (2022)

Identification of seven‐gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi‐omics data analysis
por: Zhang, Surong, et al.
Publicado: (2021)

Multi-Omics Profiling Identifies Risk Hypoxia-Related Signatures for Ovarian Cancer Prognosis
por: Chen, Xingyu, et al.
Publicado: (2021)

An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups
por: Li, Xiangyu, et al.
Publicado: (2016)

Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma
por: Gao, Xujie, et al.
Publicado: (2016)

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021)

Breast Cancer Prognostics Using Multi-Omics Data
por: Ma, Sisi, et al.
Publicado: (2016)

Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma
por: Tu, Zewei, et al.
Publicado: (2021)

Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen
por: Zamith-Miranda, Daniel, et al.
Publicado: (2019)

Multi-omics signatures of alcohol use disorder in the dorsal and ventral striatum
por: Zillich, Lea, et al.
Publicado: (2022)

Integrated Multi-Omics Signature Predicts Survival in Head and Neck Cancer
por: Ribeiro, Ilda Patrícia, et al.
Publicado: (2022)

Location-specific signatures of Crohn’s disease at a multi-omics scale
por: Gonzalez, Carlos G., et al.
Publicado: (2022)

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

Integrated Analysis of Multi-Omics Data to Establish a Hypoxia-Related Prognostic Model in Osteosarcoma
por: Tong, Ye, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jggtveb5es30nbbh06c63tt9d9